Get started
BIOMERIEUXBIOMERIEUXBIOMERIEUX

BIOMERIEUX

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Bonds

BIMX/N chart


Full chart

BIMX/N upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪303.57 B‬ MXN
Dividend yield (indicated)
0.76%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
79.10 MXN
Net income (FY)
‪9.33 B‬ MXN
Revenue (FY)
‪85.90 B‬ MXN
Shares float
‪41.28 M‬
Beta (1Y)
0.53

Employees


Employees (FY)
‪14.75 K‬
Change (1Y)
+103 +0.70%
Revenue / Employee (1Y)
‪5.82 M‬ MXN
Net income / Employee (1Y)
‪632.27 K‬ MXN

About BIOMERIEUX


Sector
Health Technology
Industry
Medical Specialties
CEO
Pierre Boulud
Website
biomerieux.com
Headquarters
Marcy l'Etoile
Founded
1967
ISIN
FR0013280286
FIGI
BBG01T2FJ2M0
bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. It develops testing, detection, and other laboratory system for the analysis of cancer, diseases, and infections caused by bacteria, virus, and fungi. The company was founded Alain Mérieux in 1963 and is headquartered in Marcy l'Etoile, France.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BIMX/N news



Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

BIMX/N highest yielding bonds


BIMAC
BIOME1.902%29JUN30
Yield to maturity
1.90%
Maturity date
Jun 29, 2030
BIMAB
BIOMER1.5%29JUN27
Yield to maturity
1.50%
Maturity date
Jun 29, 2027

See all BIMX/N bonds 


Check out other big names from the same industry as BIMX/N.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange BIOMERIEUX stocks are traded under the ticker BIMX/N.
BIMX/N stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in BIOMERIEUX price.
We've gathered analysts' opinions on BIOMERIEUX future price: according to them, BIMX/N price has a max estimate of 2,967.96 MXN and a min estimate of 1,978.64 MXN. Watch BIMX/N chart and read a more detailed BIOMERIEUX stock forecast: see what analysts think of BIOMERIEUX and suggest that you do with its stocks.
BIMX/N reached its all-time high on May 20, 2025 with the price of 2,605.80 MXN, and its all-time low was 2,605.80 MXN and was reached on May 20, 2025. View more price dynamics on BIMX/N chart.
See other stocks reaching their highest and lowest prices.
BIMX/N stock is 0.00% volatile and has beta coefficient of 0.53. Track BIOMERIEUX stock price on the chart and check out the list of the most volatile stocks — is BIOMERIEUX there?
Today BIOMERIEUX has the market capitalization of ‪302.63 B‬, it has increased by 1.58% over the last week.
Yes, you can track BIOMERIEUX financials in yearly and quarterly reports right on TradingView.
BIOMERIEUX is going to release the next earnings report on Sep 4, 2025. Keep track of upcoming events with our Earnings Calendar.
BIMX/N net income for the last half-year is ‪4.68 B‬ MXN, while the previous report showed ‪4.23 B‬ MXN of net income which accounts for 10.68% change. Track more BIOMERIEUX financial stats to get the full picture.
Yes, BIMX/N dividends are paid annually. The last dividend per share was 16.91 MXN. As of today, Dividend Yield (TTM)% is 0.73%. Tracking BIOMERIEUX dividends might help you take more informed decisions.
BIOMERIEUX dividend yield was 0.87% in 2024, and payout ratio reached 24.56%. The year before the numbers were 0.84% and 28.08% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 29, 2025, the company has ‪14.75 K‬ employees. See our rating of the largest employees — is BIOMERIEUX on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOMERIEUX EBITDA is ‪19.28 B‬ MXN, and current EBITDA margin is 22.45%. See more stats in BIOMERIEUX financial statements.
Like other stocks, BIMX/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOMERIEUX stock right from TradingView charts — choose your broker and connect to your account.